A detailed history of Arrowstreet Capital, Limited Partnership transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 14,897,625 shares of TEVA stock, worth $334 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
14,897,625
Previous 5,802,519 156.74%
Holding current value
$334 Million
Previous $94.3 Million 184.71%
% of portfolio
0.22%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $144 Million - $172 Million
9,095,106 Added 156.74%
14,897,625 $268 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $58.4 Million - $79.5 Million
4,570,086 Added 370.82%
5,802,519 $94.3 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $29.6 Million - $40 Million
-2,770,223 Reduced 69.21%
1,232,433 $17.4 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $460,452 - $602,784
56,706 Added 1.44%
4,002,656 $41.8 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $29.5 Million - $42.2 Million
3,945,950 New
3,945,950 $40.2 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $13.1 Million - $15.7 Million
-1,651,666 Reduced 97.84%
36,489 $333,000
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $5.51 Million - $9.61 Million
-803,788 Reduced 32.26%
1,688,155 $13.6 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $3.42 Million - $4.82 Million
463,456 Added 22.85%
2,491,943 $18.7 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $13.5 Million - $17.2 Million
1,835,952 Added 953.57%
2,028,487 $19 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $1.52 Million - $1.96 Million
192,535 New
192,535 $1.54 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $8.63 Million - $10.7 Million
-834,320 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $22.1 Million - $28.3 Million
-2,565,487 Reduced 75.46%
834,320 $8.05 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $12.7 Million - $18.8 Million
-1,478,630 Reduced 30.31%
3,399,807 $30.6 Million
Q2 2020

Aug 12, 2020

BUY
$8.12 - $13.12 $18 Million - $29.1 Million
2,218,983 Added 83.44%
4,878,437 $60.2 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $17.8 Million - $35.8 Million
2,659,454 New
2,659,454 $23.9 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $4.85 Million - $7.57 Million
-788,086 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $6.4 Million - $12.4 Million
788,086 New
788,086 $7.27 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $37.7 Million - $48.4 Million
-2,421,092 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $27.3 Million - $44.6 Million
1,869,786 Added 339.16%
2,421,092 $37.3 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $11.6 Million - $14.1 Million
551,306 New
551,306 $11.9 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.